Nuzenio

Tradingview Arcutis Biotherapeutics

Tradingview Arcutis Biotherapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 4 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Arcutis Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $36.62, Implies 35% Upside - TradingViewTradingView · Thu, 06 Aug 2026 13:20:06 GMTArcutis Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:39:44 GMTArcutis Biotherapeutics, Inc. 2026: Revenue $129.86M, EPS $0.11— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:26:35 GMTPrice to book forward of Arcutis Biotherapeutics, Inc. – NASDAQ:ARQT - TradingViewTradingView · Wed, 05 Aug 2026 06:49:12 GMT

Timeline

Thu, 06 Aug 2026 13:20:06 GMTArcutis Biotherapeutics, Inc. Stock 12‑Month Price Target Raised to $36.62, Implies 35% Upside - TradingView
Wed, 05 Aug 2026 21:39:44 GMTArcutis Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingView
Wed, 05 Aug 2026 20:26:35 GMTArcutis Biotherapeutics, Inc. 2026: Revenue $129.86M, EPS $0.11— 10-Q Summary - TradingView
Wed, 05 Aug 2026 06:49:12 GMTPrice to book forward of Arcutis Biotherapeutics, Inc. – NASDAQ:ARQT - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Arcutis Biotherapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.